中财网 中财网股票行情
泽璟制药(688266)财务分析指标    年份：
截止日期2026-09-302026-06-302026-03-312025-12-312025-09-30
营业总收入(万元)153649.41120537.9690539.1381048.4759344.01
营业收入(万元)153649.41120537.9690539.1381048.4759344.01
营业总成本(万元)91911.8459050.5727231.74102938.9972548.61
营业成本(万元)10688.596458.932703.757763.385694.58
净利润(万元)63830.6464003.8263260.63-16251.96-9395.40
归属于母公司的净利润(万元)63826.6664001.1163261.26-16294.62-9341.62
营业利润(万元)63695.7063866.2163228.72-16801.32-9676.26
利润总额(万元)63692.7863864.6663177.06-16865.48-9831.96
少数股东损益(万元)-------218.06-218.06
基本每股收益(元)2.41(元)2.42(元)2.39(元)-0.62(元)-0.35(元)
稀释每股收益(元)2.41(元)2.42(元)2.39(元)-0.62(元)-0.35(元)
非经常性损益(万元)--2348.97----2726.28
扣除非经常性损益后净利润(万元)60913.2761652.1463222.17-19785.52-12067.90
总资产(万元)330740.58352624.01368838.61296918.56301337.74
总负债(万元)158865.12180575.37197533.17188873.74186436.36
归属于母公司股东权益合计(万元)171875.46172048.64171305.45108044.82114901.39
股东权益合计(万元)171875.46172048.64171305.45108044.82114901.39
实收资本(股本)(万元)26470.8226470.8226470.8226470.8226470.82
资本公积(万元)310947.65310947.65310947.65310947.65310947.65
未分配利润(万元)-164142.21-163967.75-164707.61-227968.87-221015.87
经营活动产生的现金流量净额(万元)83318.2780851.3983741.45-2878.20-1673.39
经营活动现金流入小计(万元)190310.88149153.03114473.11105548.1676614.16
经营活动现金流出小计(万元)106992.6168301.6430731.66108426.3678287.55
投资活动产生的现金流量净额(万元)16401.8641243.80-60501.52-5563.44-6655.37
投资活动现金流入小计(万元)284603.07201630.9142823.8712583.236594.35
投资活动现金流出小计(万元)268201.21160387.11103325.3918146.6713249.72
筹资活动产生的现金流量净额(万元)-60613.95-33763.00-15798.17-750.10-68.50
筹资活动现金流入小计(万元)5600.005600.005600.00112688.2561602.11
筹资活动现金流出小计(万元)66213.9539363.0021398.17113438.3561670.61
期末现金及现金等价物余额(万元)50860.79100263.1019457.1512465.7713276.53
最后修改日期2026-10-302026-08-012026-04-282026-03-282025-11-01
↑返回页顶↑

转至泽璟制药（688266）行情首页

中财网免费提供股票、基金、债券、外汇、理财等行情数据以及其他资料，仅供用户获取信息。